IL17A and neoplasm: The median number of IL-17A+ cells isolated from the tumor tissue was significantly lower with respect to IL-17A-expressing cells in the PBMC (5.6% ± 3.2) and to IL-17A+ TILs isolated from BCC biopsies (19.5% ± 7) (Figure 1D).